🟢 GT Biopharma is trading 8.38% up today following 1-for-25 reverse split effective September 8, 2026

GT Biopharma is trading $5.69 (+8.38%) after its 1-for-25 reverse stock split became effective September 8, 2026.

• Nasdaq began split-adjusted trading September 8 with a new CUSIP.
• Shares outstanding fell from approximately 45.1 million to 1.8 million.
• The company said the action supports continued Nasdaq trading and streamlines its capital structure.